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Abstract
Objective—To develop a measure of illness self-management for adults living with
antineutrophil cytoplasmic antibody (ANCA)–associated small-vessel vasculitis (ANCA-SVV)
and to gather evidence of its reliability and validity.
Methods—Development of the Vasculitis Self-Management Scale (VSMS) was guided by
previous research on self-management in other chronically ill populations, a review of the current
treatment literature for ANCA-SVV, interviews with patients, and consultation with experts. A
total of 205 patients living with ANCA-SVV or a closely related condition then completed the
VSMS, along with measures of sociodemographic and clinical variables, social desirability bias,
and general adherence to medical recommendations, using a self-administered mailed
questionnaire. A principal components analysis was conducted on the VSMS items. Internal
consistency reliability and construct validity of the resulting subscales were assessed. Forty-four
patients completed the VSMS a second time, for the purpose of assessing test-retest reliability.
Results—Analyses suggested an 8-factor solution. The final VSMS consisted of 43 items
representing these 8 behavioral domains. Correlations among the 8 domains were null to modest in
magnitude. The internal consistency reliability of the 8 subscales ranged from minimally
acceptable (α = 0.67) to excellent (α = 0.94), and correlations between subscale scores at time 1
and time 2 suggested good temporal stability. Preliminary evidence for validity was mixed.
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Conclusion—These findings suggest that the VSMS is a promising method for assessing illness
self-management in adults with ANCA-SVV. More research exploring the validity of the measure
is warranted.
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INTRODUCTION
Antineutrophil cytoplasmic antibody (ANCA)–associated small-vessel vasculitis (ANCA-
SVV) is a group of rare autoimmune conditions characterized by inflammation and necrosis
of blood vessels primarily in the respiratory tract and kidneys (1). Although often fatal
without treatment (2), immunosuppressive therapy has transformed ANCA-SVV into a
chronic condition characterized by periods of remission and relapse. Patients with ANCA-
SVV face a daunting array of psychosocial and physical challenges (3,4); however, there is a
paucity of research on the psychosocial aspects of living with this condition (4).
One central psychosocial issue in ANCA-SVV is illness self-management (5), defined as the
“day-to-day tasks an individual must undertake to control or reduce the impact of disease on
physical health status” (6). Self-management usually involves treatment adherence, or “the
extent to which a person’s behavior—taking medication, following a diet, and/or executing
lifestyle changes—corresponds with agreed-upon recommendations from a health care
provider” (7), as well as other self-care tasks not explicitly recommended by health care
providers (8). ANCA-SVV self-management typically requires patients to take medications,
obtain vaccinations, regularly use health services, monitor symptoms and treatment side
effects, communicate with physicians, and make lifestyle changes (9). Self-management
tasks vary based on disease activity and comorbidities (9), and patients usually remain on
these regimens for many years, even after remission is attained (10).
Little is known about the extent to which patients with ANCA-SVV perform self-
management tasks. However, up to 50% of patients across illnesses do not adhere to doctor-
recommended behaviors (7). As in other illnesses (7,11), poor self-management in ANCA-
SVV could lead to poor outcomes including renal failure (12), impaired quality of life, and
death.
One barrier to the study of ANCA-SVV self-management and development of interventions
is the lack of an existing self-report measure that can reliably, validly, and conveniently
measure patients’ performance of self-management tasks specific to this illness. Therefore,
the first goal of the present study was to develop a self-report measure of ANCA-SVV self-
management. We sought to develop a measure with multiple self-management domains
given that nonadherence in chronic illness is known to vary across different behaviors
(7,13-15). Based on prior research in other illnesses, we expected behavioral domains to be
only modestly correlated with one another, if at all (13,14). Our second goal was to gather
evidence of the measure’s reliability and validity.
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The Vasculitis Self-Management Scale (VSMS) was developed in 4 steps: definition of the
construct and identification of specific behaviors to be measured; item generation; pilot
testing; and scale administration, item and dimensionality analysis, and reliability and
validity testing.
Identification of behaviors and initial scale development
Potential domains of self-management behavior were first identified through a review of the
ANCA-SVV literature (9,10,16). In subsequent telephone interviews, 18 adults with ANCA-
SVV described whether and how these behaviors were relevant in managing their condition,
and whether any additional behaviors were relevant. To increase the likelihood that all
behaviors relevant to a majority of patients were identified, we interviewed patients
representing a range of characteristics relevant to ANCA-SVV self-management (Table 1).
Ten adherence behaviors were identified, including adherence to self-administered
medications, medication administered by a health professional, appointments with health
professionals, recommended medical tests and immunizations, infection avoidance
behaviors, diet, exercise, symptom monitoring recommendations, mental health medication,
and appointments with mental health professionals. Also, 3 general self-care behaviors were
identified: adjusting activities based on symptoms and fatigue, prompt reporting of new or
increased symptoms to a health professional, and prompt reporting of new treatment side
effects to a health professional. Although smoking cessation, nasal irrigation, use of
nonprescribed complementary therapies (e.g., herbal remedies), and attending support group
meetings were also identified as potentially relevant, we excluded them from the measure
because the interviews revealed them to be relevant for only a small subset of patients.
Multiple items assessing performance of each behavior were then written, with guidance
from phraseology in established measures of self-care behavior (14,17,18).
Pilot testing and measure revision
We obtained 2 rounds of feedback on the content, clarity, and specificity of the draft VSMS.
First, 9 professional experts in illness self-management, scale development, and ANCA-
SVV reviewed the draft VSMS, resulting in minor changes and additional instructions to
increase its applicability to a broader range of patients. Eight additional patients, again
representing a variety of characteristics relevant to ANCA-SVV self-management (Table 1),
then completed the revised measure at home and provided feedback via telephone. Because
these interviews revealed that mental health care providers were rarely utilized, we deleted
items assessing this behavior. Also, patients typically included medications for depression,
anxiety, and sleeplessness with other self-administered medications, so separate items
assessing adherence to mental health medications were deleted.
After pilot testing, the VSMS consisted of 68 items assessing performance of the remaining
8 adherence behaviors and the 3 general self-care behaviors. Within the adherence sections,
respondents were asked if a health professional currently recommended the behavior. If the
behavior was not recommended, respondents skipped to the next section; otherwise,
respondents completed items about how frequently, using a 5-point Likert scale, they
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followed the recommendation. We followed the example of many well-validated health-
related surveys (19) that use recall of the past 4 weeks to gain stable estimates of daily
events (e.g., medication taking) and the past year for infrequent events (e.g., attending
appointments). Several items were negatively worded and reverse scored, so that higher
scores corresponded to higher levels of self-management. The 3 sections assessing general
self-care behaviors were identical in format to the adherence sections, except that all patients
completed these items unless they had not experienced any symptoms during the recall
period.
Administration and analysis of the final measure
Participants and procedures—Participants had to be 18 years or older, able to read and
write in English, and self-report a diagnosis of ANCA-SVV or a closely related condition
(Goodpasture’s disease: n = 2, temporal arteritis: n = 1). Because some patients who present
with unambiguous forms of ANCA-SVV repeatedly test negative for ANCA (20), ANCA
status was not an inclusion criterion. Participants were recruited via letters to patients
enrolled in a vasculitis disease registry and announcements in ANCA-SVV newsletters,
Web sites, and support group meetings. Through these methods, 275 eligible and interested
patients were identified and mailed consent forms, 230 (84%) provided consent, and 205
(75%) completed the study questionnaire, including the VSMS and the measures described
below. In addition, 44 of 48 (92%) randomly selected participants completed the VSMS a
second time, a mean ± SD of 6.2 ± 2.7 weeks after time 1. Participants received $10 for each
completed questionnaire.
Demographic and clinical variables—Patients provided information about their age,
sex, race/ethnicity, education, marital status, specific diagnosis, history of dialysis and
kidney transplant, and illness duration. Patients were asked to rate their current disease
activity from 1 (not active at all/remission) to 10 (extremely active).
Validation measures—Social desirability bias was assessed using the short form of the
Marlowe-Crowne Social Desirability Scale (21). This 20-item scale (Cronbach’s α = 0.77) is
widely used to determine whether answers to self-reported questionnaires are influenced by
respondents’ desires to appear in socially desired ways. Patients’ general tendency to adhere
to medical recommendations in the past 4 weeks was measured using the 5-item General
Adherence Scale (17) (Cronbach’s α = 0.70).
Statistical analysis—Analyses were conducted using SAS software, version 9.13 (SAS
Institute, Cary, NC). Because respondents were instructed to skip VSMS items if a behavior
was not relevant for managing their condition, we anticipated some missing data. We
specified a priori that VSMS items must have been completed by at least 50% of patients to
be included in the factor analysis and final measure. Although this is a relaxed standard, the
variability in patients’ self-management regimens required us to accept a higher level of
missing data if we were to create a measure that assessed a range of domains of self-
management relevant to a majority of patients, instead of a measure that only assessed 1 or 2
self-management behaviors. Because missing data were due to physicians not
recommending a particular behavior rather than issues of item validity (e.g., poor item
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wording), we chose to use this relaxed standard rather than discard useful information about
self-management behaviors that apply to most, but not all, patients with vasculitis.
Accordingly, items regarding adherence to medications administered by a health
professional, which were completed by only 52 (25%) participants, were excluded from
further analyses. The remaining 62 items were completed by a minimum of 123 (60%)
participants.
To determine the factor structure of the VSMS, we conducted a principal components
analysis (PCA) of the 62 items. To retain as many observations as possible, we analyzed the
pairwise correlation matrix, which assumes that the correlation between any 2 items
obtained from the reduced sample is an acceptable estimate of the true correlation between
those items. Cattell’s scree test (22) and parallel analysis (23) were used to determine the
optimal number of factors to extract (24,25). The scree test involves plotting eigenvalues
from highest to lowest and retaining factors that lie above the point at which the values
become horizontal, or the “elbow” (26). Parallel analysis involves comparing eigenvalues
from study data with eigenvalues produced by a PCA on multiple (n = 100 in this study)
randomly generated data sets with the same characteristics as the study data set (25). The
number of factors to retain is equal to the number of study eigenvalues that exceed the
randomly produced eigenvalues. We also evaluated these results with regard to parsimony
and plausibility. An oblique rotation, which allows factors to correlate with one another, was
then performed to determine which items loaded most highly on which factor. Guidelines in
factor analysis suggest deleting an item if it loads <0.30 on its primary factor (27,28). We
conservatively chose to retain items only if they achieved rotated factor loadings >0.40 on
their primary factor. We also discarded items that loaded >0.20 on any secondary factor.
Item sets, or subscales, were assessed for internal consistency reliability by computing
Cronbach’s alpha. Items with poor item-total correlations were eliminated from the
subscales to optimize scale brevity while maintaining acceptable internal consistency
reliability. An unweighted total score was computed for each subscale using the meanof all
retained items within the subscale. Pearson’s correlations between these final subscales were
examined.
Using data from the 44 respondents who completed the VSMS twice, we calculated several
measures of test–retest reliability for each subscale. Because the VSMS was designed to
measure adherence as a continuous phenomenon using arbitrary units (i.e., a 5-point Likert
scale), we examined relative consistency, rather than absolute agreement, of individuals’
scores over time. Two measures of relative consistency for each subscale across the 2
administrations were evaluated (29): Pearson’s product-moment correlation (r) and the (3,1)
intraclass correlation coefficient (ICC) (30). Paired t-tests were used to detect systematic
shifts in subscale scores between time 1 and time 2.
As a preliminary evaluation of validity (26), we examined Pearson’s correlations between
participants’ scores on the VSMS subscales and their scores on the social desirability and
general adherence measures. We expected that VSMS scores would be 1) minimally
correlated with respondents’ tendencies to report in socially desirable ways and 2) positively
and significantly correlated with General Adherence Scale scores. Because reporting of
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general adherence to medical recommendations likely reflects a combination of adherence to
each individual behavioral recommendation, we expected the latter to be small to moderate
in magnitude, such as has been described for adherence in diabetes (17). Multivariable linear
regression was used to further explore the relationship between general adherence and
VSMS scores, controlling for social desirability bias, a potential confounder.
RESULTS
Sample characteristics
Participant characteristics are shown in Table 2. Approximately half of the participants were
women, and almost all were white. The mean age was 54.7 years (range 18–83), and the
average education level was some college. The most common diagnosis was Wegener’s
granulomatosis (70.7%), and mean illness duration was 75.6 months (6.3 years). Thirty-one
percent reported that their illness was currently in remission (either with or without
medication). The characteristics of this sample are similar to those previously reported for
US samples of adults with systemic vasculitis (10,31). Bivariable linear regression analyses
failed to reveal significant differences between characteristics of the subsample who
completed the VSMS twice versus the rest of the sample.
Factor structure
The scree test revealed 2 elbows, one indicating a 9-factor solution and another indicating a
7-factor solution. The parallel analysis indicated a 9-factor solution. Because of these
ambiguous results, we examined solutions for 7, 8, and 9 factors. The 8-factor solution
resulted in the fewest number of cross-loadings and distinct factors that were theoretically
coherent, and accounted for 58.2% of the total variance. The 8 factors included 6 adherence
domains: medication, recommended health services (including adherence to medical tests
and immunizations and attending appointments with health professionals), infection
avoidance, diet, exercise, and symptom monitoring adherence. The remaining factors
consisted of 2 general self-care domains: prompt reporting of symptoms and side effects and
adjusting activities in response to fatigue and symptoms.
To construct the final 8 subscales, we deleted 15 items that exhibited cross-loadings >0.20.
We then deleted 1 item from the exercise adherence subscale that resulted in an
improvement in Cronbach’s alpha. Three of 10 remaining items from the reporting
symptoms and side effects subscale were deleted to decrease its length while maintaining
alpha >0.90. The final 8-factor VSMS consisted of 43 items (see Appendix A, available at
the Arthritis Care & Research Web site at http://www.interscience.wiley.com/jpages/
0004-3591:1/suppmat/index.html).
Correlations between subscales are shown in Table 3. As expected, correlations between
these 8 factors were null to modest, ranging from r =−0.003 to r = 0.37.
Reliability
Descriptive and test–retest statistics for the 8 subscales at time 1 and time 2 are shown in
Table 4. Internal consistency reliability (at time 1) ranged from minimally acceptable for the
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adjusting activities subscale (α = 0.67) to excellent for the exercise adherence subscale (α =
0.94). Test–retest Pearson’s correlations ranged from r = 0.56 for health services adherence
to r = 0.79 for exercise adherence. ICCs were similar in magnitude to Pearson’s correlations.
Scores on the 8 subscales at time 2 did not differ from time 1, except for infection avoidance
adherence, which was higher at time 2 (mean ± SD difference 0.22 ± 0.54, t = 2.13, df 26, P
< 0.05).
Validity
As expected, participants’ social desirability scores demonstrated nonsignificant correlations
with exercise (r = 0.05), infection avoidance (r = 0.15), and diet (r = 0.14) adherence.
Contrary to expectations, scores on the medication (r = 0.26, P < 0.01), health services (r =
0.15, P < 0.05), symptom monitoring (r = 0.22, P < 0.05), reporting symptoms and side
effects (r = 0.19, P < 0.05), and adjusting activities (r = 0.17, P < 0.05) subscales were
modestly but significantly associated with social desirability. As expected, general
adherence was positively and significantly related to medication (r = 0.26, P < 0.01), diet (r
= 0.31, P < 0.01), exercise (r = 0.39, P < 0.01), and symptom monitoring (r = 0.26, P < 0.01)
adherence, and reporting symptoms and side effects (r = 0.20, P < 0.01). These relationships
remained substantively unchanged after controlling for social desirability. Unexpectedly,
general adherence was not related to health services adherence (r = 0.13), infection
avoidance adherence (r = 0.10), or adjusting activities (r = 0.05).
DISCUSSION
To our knowledge, this is the first study of ANCA-SVV self-management. Our results
indicate that 8 behaviors are relevant for a majority of patients, including medication, health
services, infection avoidance, diet, exercise, and symptom monitoring adherence; prompt
reporting of symptoms and side effects; and adjusting activities in response to symptoms.
One hypothesized domain, adherence to medications administered by health professionals,
only pertained to a minority of patients. This may have been due to the long illness duration
reported by most of the study participants, because intravenous medication is often
discontinued after achieving initial remission. Future studies should evaluate these items
with a larger sample of patients currently taking such medication. In addition, although we
initially thought that items assessing appointment keeping and obtaining tests and
immunizations would factor separately, factor loadings suggested one factor representing
both behaviors. However, the loadings for appointment-keeping items were somewhat lower
and more ambiguous than those for medical tests and immunizations, leading to elimination
of all but one of these items from the final subscale. Given this loading pattern and the
ambiguous results of the scree test and parallel analysis, it may be prudent to retain and
reexamine all appointment-keeping, test, and immunization items in future studies. Overall,
however, the factor loadings for the items retained in the final subscales lend strong support
for the 8-factor solution in this study. All final subscales include at least 3 items with very
good (>0.63) or excellent (>0.70) (27) loadings on their primary factor, with no secondary
loading greater than 0.20.
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This study also confirmed that ANCA-SVV self-management behaviors are relatively
independent of one another. All intersubscale correlations were well below the cutoff of r =
0.70 considered high enough to result in factor interpretation errors (32). These correlations
are also consistent with prior research in other illness contexts (7), with previously reported
correlations between diet and exercise adherence of r = 0.27–0.34 (14), comparable with the
r = 0.35 found in this study.
All 8 subscales appear to have acceptable internal consistency reliability. Only the adjusting
activities subscale had a Cronbach’s alpha <0.70, but performed above this benchmark (26)
at time 2. Also, all subscales demonstrated temporal stability, in terms of both relative
consistency as measured by Pearson’s r and the ICC, and a lack of systematic shift in mean
scores over time. Although the increase in mean score for the infection avoidance adherence
subscale across the 2 administrations was statistically significant, it represents only a 6%
increase in scores on average. The observed temporal consistency is impressive, given that
test–retest reliability estimates may be artificially reduced due to real changes in the
construct across the administration interval (28), which is possible with regard to self-
management behavior over a 6-week period.
Observed correlations between VSMS subscales and the measures of social desirability bias
and general adherence demonstrated promising but mixed support for construct validity. The
diet and exercise adherence subscales performed the best in relation to these measures,
whereas the adherence to recommended health services and adjusting activities subscales
performed the least well. The positive associations between scores on the social desirability
scale and 5 of the 8 self-management subscales are, at first glance, concerning. However,
these correlations tended to be modest (r < 0.30 for all) and similar to those found with other
self-report measures of self-management with otherwise good evidence of validity (17).
Future VSMS users should assess and control for social desirability bias, as was done in this
study. It is also encouraging that scores on the General Adherence Scale, a measure that is
positively associated with objective measures of disease control (e.g., blood glucose, blood
pressure, body mass index) among patients with type II diabetes, hypertension, and heart
disease (18), were significantly and positively correlated with the medication, diet, exercise,
symptom monitoring, and reporting subscales, even after taking into account patients’ social
desirability bias. These observed correlations, which ranged from r = 0.20 to r = 0.39, are
similar in magnitude to the modest correlations between behavior specific and general
adherence observed in other illness populations (17,18).
Although our overall results demonstrate promising evidence of the VSMS’s validity, our
approach to assessing validity was limited due to feasibility issues. Ideally, we would have
also examined correlations of VSMS scores with objective measures of self-management
behavior (e.g., medication levels in blood, clinic appointment records). Exploring
relationships between VSMS scores and measures of disease control (e.g., blood and protein
levels in urine, scores on validated disease activity scales) or complications (e.g., incidence
of infections) would also help evaluate the validity of the VSMS.
Several other limitations of this study should be noted. First, our sample was relatively
small, especially taking into account missing data. However, we took advantage of all
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available data by using the pairwise correlation matrix in the PCA, and a plausible factor
solution did emerge. Also, we relied on patient recall for assessing which behaviors were
explicitly recommended by a health professional; thus, the 6 adherence subscales actually
measure perceived adherence. Future research should compare physician reports with patient
recall of behavioral recommendations on the VSMS to determine rates of unintentional
nonadherence.
Despite these limitations, this study presents a promising approach for measuring self-
management in patients with ANCA-SVV. The measure offers a convenient, flexible way to
assess a comprehensive set of self-management behaviors relevant for a majority of patients.
Furthermore, its self-report format allows for assessment of behaviors not easily measured
using objective measures (e.g., infection avoidance behavior). The multidimensionality of
the measure conforms with what is known about self-management in other illnesses, and
reliability of each subscale appears acceptable. Although evidence for validity is incomplete,
future research can build on our results. If this evidence further supports the measure’s
validity, it will likely prove useful in both clinical and research settings.
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Table 1













 <1 2 1
 ≥1 16 7
Current disease activity
No symptoms of active
  disease
5 4




 Taking medication for ANCA-
  SVV or its complications
18 8
 Not taking any medication for




 Currently on dialysis 1 1
 Not currently on dialysis 17 7
Transplant history
 History of kidney transplant 2 1




 No other conditions unrelated
  to ANCA-SVV
11 4
 At least one other condition
  unrelated to ANCA-SVV
7 4
*
Values are the number of participants. ANCA-SVV = antineutrophil cytoplasmic antibody–associated small-vessel vasculitis.
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Table 2
Characteristics of individuals completing the 68-item Vasculitis Self-Management Scale at







  Male 46.3 40.9
  Female 53.7 59.1
 Race/ethnicity
  White 93.6 93.0
  American Indian/Alaskan Native 1.0 0
  Asian 2.5 2.3
  African American 1.0 2.3
  Hispanic/Latino 2.0 2.3
 Age, mean ± SD years (range 18–83) 54.7 ± 14.7 56.5 ± 14.8
 Education, mean ± SD years 14.6 ± 2.4 15.1 ± 2.3
 Marital status
  Married 74.2 75.0
  Nonmarried 25.9 25.0
Clinical characteristics
 Diagnosed condition
  Wegener’s granulomatosis 70.7 68.2
  Microscopic polyangiitis 7.8 9.1
  Churg-Strauss syndrome 4.9 4.6
  ANCA-glomerulonephritis 15.1 18.2
  Goodpasture’s disease 1.0 0
  Temporal arteritis 0.5 0
 Time since diagnosis, mean ± SD months 75.7 ± 70.7 88.5 ± 88.3
Patient-perceived disease activity score,
   mean ± SD (range 1–10) 2.9 ± 2.1 2.2 ± 1.5
 Ever on dialysis 15.8 16.3
 Currently on dialysis 3.5 0
 History of kidney transplant 7.5 11.4
*
Values are the percentage unless otherwise indicated. ANCA = antineutrophil cytoplasmic antibody.






















THORPE et al. Page 13
Table 3
Pearson’s correlations between the 8 final subscales of the Vasculitis Self-Management
Scale*





Medication 1.0 (191) – – – – – – –
Health services 0.23 (188)† 1.0 (202) – – – – – –
Infection 0.17 (132) −0.04 (141) 1.0 (142) – – – – –
Diet 0.19 (145)‡ 0.12 (152) 0.24 (120)† 1.0 (154) – – – –
Exercise 0.21 (121)‡ 0.06 (125) −0.03 (98) 0.35 (101)† 1.0 (125) – – –
Symptom
 monitoring 0.19 (123)‡ 0.08 (131) 0.37 (102)§ 0.21 (117)‡ 0.37 (93)§ 1.0 (133) – –
Reporting 0.25 (167)† 0.26 (175)§ 0.20 (128)‡ 0.12 (141) 0.07 (110) 0.34 (118)§ 1.0 (177) –
Adjusting
 activities 0.15 (172)‡ −0.003 (182) 0.25 (131)† 0.33 (141)§ 0.07 (118) 0.16 (124) 0.19 (163)‡ 1.0 (185)
*
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Table 4
Descriptive and test–retest statistics for the 8 subscales of the Vasculitis Self-Management
Scale at times 1 and 2*
Time 1 Time 2 Test–retest statistics





Medication adherence 191 4.5 ± 0.54 0.77 43 4.6 ± 0.52 0.87 0.06 ± 0.44 0.60† 0.61
Health services adherence 202 4.6 ± 0.63 0.78 44 4.6 ± 0.58 0.73 −0.01 ± 0.51 0.56† 0.54
Infection avoidance adherence 142 3.7 ± 0.79 0.85 33 3.9 ± 0.73 0.84 0.22 ± 0.54‡ 0.67† 0.69
Diet adherence 154 3.6 ± 0.76 0.76 34 3.6 ± 0.73 0.71 −0.16 ± 0.59 0.65† 0.60
Exercise adherence 125 3.2 ± 1.02 0.94 29 2.8 ± 0.94 0.96 −0.22 ± 0.67 0.79† 0.75
Symptom monitoring adherence 133 3.8 ± 0.97 0.91 29 3.5 ± 1.07 0.94 −0.20 ± 0.92 0.68† 0.63
Reporting symptoms and side effects 177 3.2 ± 1.08 0.90 40 3.1 ± 1.02 0.86 −0.11 ± 0.70 0.76† 0.76
Adjusting activities 185 3.4 ± 0.64 0.67 40 3.5 ± 0.62 0.71 0.10 ± 0.42 0.77† 0.76
*
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